Abstract
Brain derived neurotrophic factor (BDNF) plays important roles in neuronal survival, axonal and dendritic growth, synaptic plasticity, learning and memory and emotional behavior. Recently, a single nucleotide polymorphism (SNP) in the BDNF gene leading to a valine to methionine substitution at position 66 in BDNF prodomain (Val66Met) has been found to decrease activity-dependent BDNF secretion and to be associated with increased susceptibility to neuropsychiatric disorders. BDNF Val66Met polymorphism only exists in human and represents the first genetic alteration in a neurotrophin that has been linked to a human disease. In this chapter, we will focus on the biological consequences of BDNFVal66Met polymorphism in the context of central nervous system structure and function with combined molecular and cellular, human behavioral and imaging, and transgenic mouse studies.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
An, J. J., Gharami, K., Liao, G. Y., Woo, N. H., Lau, A. G., Vanevski, F., Torre, E. R., Jones, K. R., Feng, Y., Lu, B., & Xu, B. (2008). Distinct role of long 3’ UTR BDNF mRNA in spine morphology and synaptic plasticity in hippocampal neurons. Cell, 134, 175–187.
Bramham, C. R., & Messaoudi, E. (2005). BDNF function in adult synaptic plasticity: The synaptic consolidation hypothesis. Progress in Neurobiology, 76, 99–125.
Bueller, J. A., Aftab, M., Sen, S., Gomez-Hassan, D., Burmeister, M., & Zubieta, J. K. (2006). BDNF Val66Met allele is associated with reduced hippocampal volume in healthy subjects. Biological Psychiatry, 59, 812–815.
Bukh, J. D., Bock, C., Vinberg, M., Werge, T., Gether, U., & Vedel Kessing, L. (2009). Interaction between genetic polymorphisms and stressful life events in first episode depression. Journal of Affective Disorders, 119, 107–115.
Carver, C. S., Johnson, S. L., Joormann, J., Lemoult, J., & Cuccaro, M. L. (2011). Childhood adversity interacts separately with 5-HTTLPR and BDNF to predict lifetime depression diagnosis. Journal of Affective Disorders, 132, 89–93.
Castren, E., & Rantamaki, T. (2010). The role of BDNF and its receptors in depression and antidepressant drug action: Reactivation of developmental plasticity. Developmental Neurobiology, 70, 289–297.
Chao, M. V. (2003). Neurotrophins and their receptors: A convergence point for many signalling pathways. Nature Reviews Neuroscience, 4, 299–309.
Chao, M. V., Rajagopal, R., & Lee, F. S. (2006). Neurotrophin signalling in health and disease. Clinical Science (London), 110, 167–173.
Chen, Z. Y., Patel, P. D., Sant, G., Meng, C. X., Teng, K. K., Hempstead, B. L., & Lee, F. S. (2004). Variant brain-derived neurotrophic factor (BDNF) (Met66) alters the intracellular trafficking and activity-dependent secretion of wild-type BDNF in neurosecretory cells and cortical neurons. Journal of Neuroscience, 24, 4401–4411.
Chen, Z. Y., Ieraci, A., Teng, H., Dall, H., Meng, C. X., Herrera, D. G., Nykjaer, A., Hempstead, B. L., & Lee, F. S. (2005). Sortilin controls intracellular sorting of brain-derived neurotrophic factor to the regulated secretory pathway. Journal of Neuroscience, 25, 6156–6166.
Chen, Z. Y., Jing, D., Bath, K. G., Ieraci, A., Khan, T., Siao, C. J., Herrera, D. G., Toth, M., Yang, C., McEwen, B. S., Hempstead, B. L., & Lee, F. S. (2006). Genetic variant BDNF (Val66Met) polymorphism alters anxiety-related behavior. Science, 314, 140–143.
Chepenik, L. G., Fredericks, C., Papademetris, X., Spencer, L., Lacadie, C., Wang, F., Pittman, B., Duncan, J. S., Staib, L. H., Duman, R. S., Gelernter, J., & Blumberg, H. P. (2009). Effects of the brain-derived neurotrophic growth factor val66met variation on hippocampus morphology in bipolar disorder. Neuropsychopharmacology, 34, 944–951.
Chiaruttini, C., Vicario, A., Li, Z., Baj, G., Braiuca, P., Wu, Y., Lee, F. S., Gardossi, L., Baraban, J. M., & Tongiorgi, E. (2009). Dendritic trafficking of BDNF mRNA is mediated by translin and blocked by the G196A (Val66Met) mutation. Proceedings of the National Academy of Sciences U S A, 106, 16481–16486.
Egan, M. F., Kojima, M., Callicott, J. H., Goldberg, T. E., Kolachana, B. S., Bertolino, A., Zaitsev, E., Gold, B., Goldman, D., Dean, M., Lu, B., & Weinberger, D. R. (2003). The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell, 112, 257–269.
Frodl, T., Schule, C., Schmitt, G., Born, C., Baghai, T., Zill, P., Bottlender, R., Rupprecht, R., Bondy, B., Reiser, M., Moller, H. J., & Meisenzahl, E. M. (2007). Association of the brain-derived neurotrophic factor Val66Met polymorphism with reduced hippocampal volumes in major depression. Archives of General Psychiatry, 64, 410–416.
Hariri, A. R., Goldberg, T. E., Mattay, V. S., Kolachana, B. S., Callicott, J. H., Egan, M. F., & Weinberger, D. R. (2003). Brain-derived neurotrophic factor val66met polymorphism affects human memory-related hippocampal activity and predicts memory performance. Journal of Neuroscience, 23, 6690–6694.
Ho, B. C., Milev, P., O'Leary, D. S., Librant, A., Andreasen, N. C., & Wassink, T. H. (2006). Cognitive and magnetic resonance imaging brain morphometric correlates of brain-derived neurotrophic factor Val66Met gene polymorphism in patients with schizophrenia and healthy volunteers. Archives of General Psychiatry, 63, 731–740.
Ho, B. C., Andreasen, N. C., Dawson, J. D., & Wassink, T. H. (2007). Association between brain-derived neurotrophic factor Val66Met gene polymorphism and progressive brain volume changes in schizophrenia. The American Journal of Psychiatry, 164, 1890–1899.
Huang, E. J., & Reichardt, L. F. (2001). Neurotrophins: Roles in neuronal development and function. Annual Review of Neuroscience, 24, 677–736.
Huang, E. J., & Reichardt, L. F. (2003). Trk receptors: Roles in neuronal signal transduction. Annual Review of Biochemistry, 72, 609–642.
Jiang, X., Xu, K., Hoberman, J., Tian, F., Marko, A. J., Waheed, J. F., Harris, C. R., Marini, A. M., Enoch, M. A., & Lipsky, R. H. (2005). BDNF variation and mood disorders: A novel functional promoter polymorphism and Val66Met are associated with anxiety but have opposing effects. Neuropsychopharmacology, 30, 1353–1361.
Kaufman, J., Yang, B. Z., Douglas-Palumberi, H., Grasso, D., Lipschitz, D., Houshyar, S., Krystal, J. H., & Gelernter, J. (2006). Brain-derived neurotrophic factor-5-HTTLPR gene interactions and environmental modifiers of depression in children. Biological Psychiatry, 59, 673–680.
Kim, J. M., Stewart, R., Kim, S. W., Yang, S. J., Shin, I. S., Kim, Y. H., & Yoon, J. S. (2008). BDNF genotype potentially modifying the association between incident stroke and depression. Neurobiology of Aging, 29, 789–792.
Krishnan, V., & Nestler, E. J. (2010). Linking molecules to mood: New insight into the biology of depression. The American Journal of Psychiatry, 167, 1305–1320.
Lang, U. E., Hellweg, R., Kalus, P., Bajbouj, M., Lenzen, K. P., Sander, T., Kunz, D., & Gallinat, J. (2005). Association of a functional BDNF polymorphism and anxiety-related personality traits. Psychopharmacology (Berl), 180, 95–99.
Lessmann, V., Gottmann, K., & Malcangio, M. (2003). Neurotrophin secretion: Current facts and future prospects. Progress in Neurobiology, 69, 341–374.
Lu, B. (2003). BDNF and activity-dependent synaptic modulation. Learning & Memory, 10, 86–98.
Lu, B., Pang, P. T., & Woo, N. H. (2005). The yin and yang of neurotrophin action. Nature Reviews Neuroscience, 6, 603–614.
Masaki, T., Matsushita, S., Arai, H., Takeda, A., Itoyama, Y., Mochizuki, H., Kamakura, K., Ohara, S., & Higuchi, S. (2003). Association between a polymorphism of brain-derived neurotrophic factor gene and sporadic Parkinson’s disease. Annals of Neurology, 54, 276–277.
Matsuo, K., Walss-Bass, C., Nery, F. G., Nicoletti, M. A., Hatch, J. P., Frey, B. N., Monkul, E. S., Zunta-Soares, G. B., Bowden, C. L., Escamilla, M. A., & Soares, J. C. (2009). Neuronal correlates of brain-derived neurotrophic factor Val66Met polymorphism and morphometric abnormalities in bipolar disorder. Neuropsychopharmacology, 34, 1904–1913.
McHughen, S. A., Rodriguez, P. F., Kleim, J. A., Kleim, E. D., Marchal Crespo, L., Procaccio, V., & Cramer, S. C. (2010). BDNF val66met polymorphism influences motor system function in the human brain. Cerebral Cortex, 20, 1254–1262.
Mirakhur, A., Moorhead, T. W., Stanfield, A. C., McKirdy, J., Sussmann, J. E., Hall, J., Lawrie, S. M., Johnstone, E. C., & McIntosh, A. M. (2009). Changes in gyrification over 4 years in bipolar disorder and their association with the brain-derived neurotrophic factor valine(66) methionine variant. Biological Psychiatry, 66, 293–297.
Mowla, S. J., Pareek, S., Farhadi, H. F., Petrecca, K., Fawcett, J. P., Seidah, N. G., Morris, S. J., Sossin, W. S., & Murphy, R. A. (1999). Differential sorting of nerve growth factor and brain-derived neurotrophic factor in hippocampal neurons. The Journal of Neuroscience, 19, 2069–2080.
Nagappan, G., Zaitsev, E., Senatorov, V. V., Jr., Yang, J., Hempstead, B. L., & Lu, B. (2009). Control of extracellular cleavage of ProBDNF by high frequency neuronal activity. Proceedings of the National Academy of Sciences U S A, 106, 1267–1272.
Nederhof, E., Bouma, E. M., Oldehinkel, A. J., & Ormel, J. (2010). Interaction between childhood adversity, brain-derived neurotrophic factor val/met and serotonin transporter promoter polymorphism on depression: The TRAILS study. Biological psychiatry, 68, 209–212.
Neves-Pereira, M., Mundo, E., Muglia, P., King, N., Macciardi, F., & Kennedy, J. L. (2002). The brain-derived neurotrophic factor gene confers susceptibility to bipolar disorder: Evidence from a family-based association study. American Journal of Human Genetics, 71, 651–655.
Pang, P. T., Teng, H. K., Zaitsev, E., Woo, N. T., Sakata, K., Zhen, S., Teng, K. K., Yung, W. H., Hempstead, B. L., & Lu, B. (2004). Cleavage of proBDNF by tPA/plasmin is essential for long-term hippocampal plasticity. Science, 306, 487–491.
Pezawas, L., Verchinski, B. A., Mattay, V. S., Callicott, J. H., Kolachana, B. S., Straub, R. E., Egan, M. F., Meyer-Lindenberg, A., & Weinberger, D. R. (2004). The brain-derived neurotrophic factor val66met polymorphism and variation in human cortical morphology. The Journal of Neuroscience, 24, 10099–10102.
Ribases, M., Gratacos, M., Armengol, L., de Cid, R., Badia, A., Jimenez, L., Solano, R., Vallejo, J., Fernandez, F., & Estivill, X. (2003). Met66 in the brain-derived neurotrophic factor (BDNF) precursor is associated with anorexia nervosa restrictive type. Molecular Psychiatry, 8, 745–751.
Roux, P. P., & Barker, P. A. (2002). Neurotrophin signaling through the p75 neurotrophin receptor. Progress in Neurobiology, 67, 203–233.
Rybakowski, J. K., Borkowska, A., Czerski, P. M., Skibinska, M., & Hauser, J. (2003). Polymorphism of the brain-derived neurotrophic factor gene and performance on a cognitive prefrontal test in bipolar patients. Bipolar Disorders, 5, 468–472.
Schumacher, J., Jamra, R. A., Becker, T., Ohlraun, S., Klopp, N., Binder, E. B., Schulze, T. G., Deschner, M., Schmal, C., Hofels, S., Zobel, A., Illig, T., Propping, P., Holsboer, F., Rietschel, M., Nothen, M. M., & Cichon, S. (2005). Evidence for a relationship between genetic variants at the brain-derived neurotrophic factor (BDNF) locus and major depression. Biological Psychiatry, 58, 307–314.
Schuman, E. M. (1999). Neurotrophin regulation of synaptic transmission. Current Opinion in Neurobiology, 9, 105–109.
Sen, S., Nesse, R. M., Stoltenberg, S. F., Li, S., Gleiberman, L., Chakravarti, A., Weder, A. B., & Burmeister, M. (2003). A BDNF coding variant is associated with the NEO personality inventory domain neuroticism, a risk factor for depression. Neuropsychopharmacology, 28, 397–401.
Shimizu, E., Hashimoto, K., & Iyo, M. (2004). Ethnic difference of the BDNF 196G/A (val66met) polymorphism frequencies: The possibility to explain ethnic mental traits. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics, 126B, 122–123.
Sklar, P., Gabriel, S. B., McInnis, M. G., Bennett, P., Lim, Y. M., Tsan, G., Schaffner, S., Kirov, G., Jones, I., Owen, M., Craddock, N., DePaulo, J. R., & Lander, E. S. (2002). Family-based association study of 76 candidate genes in bipolar disorder: BDNF is a potential risk locus. Brain-derived neutrophic factor. Molecular Psychiatry, 7, 579–593.
Soliman, F., Glatt, C. E., Bath, K. G., Levita, L., Jones, R. M., Pattwell, S. S., Jing, D., Tottenham, N., Amso, D., Somerville, L. H., Voss, H. U., Glover, G., Ballon, D. J., Liston, C., Teslovich, T., Van Kempen, T., Lee, F. S., & Casey, B. J. (2010). A genetic variant BDNF polymorphism alters extinction learning in both mouse and human. Science, 327, 863–866.
Suter, U., Heymach, J. V., Jr., & Shooter, E. M. (1991). Two conserved domains in the NGF propeptide are necessary and sufficient for the biosynthesis of correctly processed and biologically active NGF. The EMBO Journal, 10, 2395–2400.
Szeszko, P. R., Lipsky, R., Mentschel, C., Robinson, D., Gunduz-Bruce, H., Sevy, S., Ashtari, M., Napolitano, B., Bilder, R. M., Kane, J. M., Goldman, D., & Malhotra, A. K. (2005). Brain-derived neurotrophic factor val66met polymorphism and volume of the hippocampal formation. Molecular Psychiatry, 10, 631–636.
Teng, K. K., & Hempstead, B. L. (2004). Neurotrophins and their receptors: Signaling trios in complex biological systems. Cellular and Molecular Life Sciences, 61, 35–48.
Teng, H. K., Teng, K. K., Lee, R., Wright, S., Tevar, S., Almeida, R. D., Kermani, P., Torkin, R., Chen, Z. Y., Lee, F. S., Kraemer, R. T., Nykjaer, A., & Hempstead, B. L. (2005). ProBDNF induces neuronal apoptosis via activation of a receptor complex of p75NTR and sortilin. The Journal of Neuroscience, 25, 5455–5463.
Tongiorgi, E., & Baj, G (2008) Functions and mechanisms of BDNF mRNA trafficking. Novartis found Symposium 289:136–147; discussion 147–151, 193–135.
Ventriglia, M., Bocchio Chiavetto, L., Benussi, L., Binetti, G., Zanetti, O., Riva, M. A., & Gennarelli, M. (2002). Association between the BDNF 196 A/G polymorphism and sporadic Alzheimer's disease. Molecular Psychiatry, 7, 136–137.
Yang, J., Siao, C. J., Nagappan, G., Marinic, T., Jing, D., McGrath, K., Chen, Z. Y., Mark, W., Tessarollo, L., Lee, F. S., Lu, B., & Hempstead, B. L. (2009). Neuronal release of proBDNF. Nature Neuroscience, 12, 113–115.
Yu, H., Wang, Y., Pattwell, S., Jing, D., Liu, T., Zhang, Y., Bath, K. G., Lee, F. S., & Chen, Z. Y. (2009). Variant BDNF Val66Met polymorphism affects extinction of conditioned aversive memory. Journal of Neuroscience, 29, 4056–4064.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this entry
Cite this entry
Chen, ZY. (2014). BDNF V66M Polymorphism and Brain Functions. In: Kostrzewa, R. (eds) Handbook of Neurotoxicity. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-5836-4_32
Download citation
DOI: https://doi.org/10.1007/978-1-4614-5836-4_32
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-5835-7
Online ISBN: 978-1-4614-5836-4
eBook Packages: Biomedical and Life SciencesReference Module Biomedical and Life Sciences